These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Gastric emptying and release of incretin hormones after glucose ingestion in humans. Schirra J, Katschinski M, Weidmann C, Schäfer T, Wank U, Arnold R, Göke B. J Clin Invest; 1996 Jan 01; 97(1):92-103. PubMed ID: 8550855 [Abstract] [Full Text] [Related]
23. Interactions between gastric emptying and satiety, with special reference to glucagon-like peptide-1. Hellström PM, Näslund E. Physiol Behav; 2001 Jan 01; 74(4-5):735-41. PubMed ID: 11790437 [Abstract] [Full Text] [Related]
25. Involvement of endogenous glucagon-like peptide-1 in regulation of gastric motility and pancreatic endocrine secretion. Witte AB, Grybäck P, Jacobsson H, Näslund E, Hellström PM, Holst JJ, Hilsted L, Schmidt PT. Scand J Gastroenterol; 2011 Apr 01; 46(4):428-35. PubMed ID: 21114428 [Abstract] [Full Text] [Related]
26. Effects of glucagon-like peptide-1(7-36)amide on motility and sensation of the proximal stomach in humans. Schirra J, Wank U, Arnold R, Göke B, Katschinski M. Gut; 2002 Mar 01; 50(3):341-8. PubMed ID: 11839712 [Abstract] [Full Text] [Related]
34. The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal. Frost GS, Brynes AE, Dhillo WS, Bloom SR, McBurney MI. Eur J Clin Nutr; 2003 Feb 01; 57(2):293-8. PubMed ID: 12571662 [Abstract] [Full Text] [Related]
36. Effects of nitric oxide on antral motility and gastric emptying in humans. Konturek JW, Thor P, Domschke W. Eur J Gastroenterol Hepatol; 1995 Feb 01; 7(2):97-102. PubMed ID: 7712314 [Abstract] [Full Text] [Related]
37. Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans. Delgado-Aros S, Kim DY, Burton DD, Thomforde GM, Stephens D, Brinkmann BH, Vella A, Camilleri M. Am J Physiol Gastrointest Liver Physiol; 2002 Mar 01; 282(3):G424-31. PubMed ID: 11841992 [Abstract] [Full Text] [Related]
39. The inhibitory effect of glucagon-like peptide-1 (7-36)amide on antral motility is antagonized by its N-terminally truncated primary metabolite GLP-1 (9-36)amide. Wettergren A, Wøjdemann M, Holst JJ. Peptides; 1998 Mar 01; 19(5):877-82. PubMed ID: 9663453 [Abstract] [Full Text] [Related]
40. Glucagon-like peptide-1 7-36 amide and peptide YY have additive inhibitory effect on gastric acid secretion in man. Wettergren A, Maina P, Boesby S, Holst JJ. Scand J Gastroenterol; 1997 Jun 01; 32(6):552-5. PubMed ID: 9200286 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]